Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-04-17

Clinical Trial Update: Improving Substance Use and Clinical Outcomes in Heavy Cannabis Users With Quetiapine [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating quetiapine for cannabis use disorder has completed, with updates on substance use and clinical outcomes in heavy cannabis users.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Quetiapine (quetiapine)

Snippet

Sponsor: Northwell Health | Conditions: Cannabis Dependence | Phase 4 | Status: COMPLETED